Tobacco-free Kids Action Fund

Spending by Year

Lobbying Firms

What They Lobby For

• Monitor general issues regarding Food and Drug Administration tobacco product regulations and Centers for Disease Control and Prevention cessation programs; highlight connection between health disparities and tobacco use. Specifically, H.R. 564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 1136 FDA Deeming Authority Clarification Act of 2017 H.R. 4273 House Tobacco to 21 Act H.R. 3268 House FY2018 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies H.R. 3358 House FY2018 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies H.R.195 FY18 Appropriations Continuing Resolution through February 8 H.R. 1625 FY18 Consolidated Appropriations Act, 2018 H.R. 1892 FY18 Appropriations Continuing Resolution through March 23 House FY2019 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies House FY2019 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies
• Monitor general issues regarding Food and Drug Administration tobacco product regulations and Centers for Disease Control and Prevention cessation programs, including House FY2019 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; highlight connection between health disparities and tobacco use
• Monitor general issues regarding Food and Drug Administration tobacco product regulations and Centers for Disease Control and Prevention cessation programs, including H.R. 1136 FDA Deeming Authority Clarification Act of 2017; H.R. 4273 House Tobacco to 21 Act; H.R. 5961 House FY2019 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; highlighting connection between health disparities and tobacco use
• Monitor general issues regarding Food and Drug Administration tobacco product regulations and Centers for Disease Control and Prevention cessation programs, including funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) and authorized level of user fees for FDA regulations; highlight connection between health disparities and tobacco use.
• Monitor general issues regarding Food and Drug Administration tobacco product regulations and Centers for Disease Control and Prevention cessation programs, including funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) and authorized level of user fees for FDA regulations; highlight connection between health disparities and tobacco use; H.R. 2339 Reversing the Youth Tobacco Epidemic Act of 2019; H.R. 2411 Tobacco to 21 Act
• Monitor general issues regarding H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019; H.R. 2411 Tobacco to 21 Act; Food and Drug Administration tobacco product regulations and Centers for Disease Control and Prevention cessation programs, including funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) and authorized level of user fees for FDA regulations; highlight connection between health disparities and tobacco use
• Monitor general issues regarding H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019; Food and Drug Administration tobacco product regulations and Centers for Disease Control and Prevention cessation programs; efforts to enhance Medicaid eligibility for tobacco cessation programs during COVID-19; highlight connection between health disparities and tobacco use
• FY '22 appropriations for the Centers for Disease Control and Prevention in the House FY '22 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies; H.R. 2125, Quit Because of COVID-19 Act; Issues regarding health disparities and tobacco marketing; FDA regulation of tobacco products, including flavored e-cigarettes and menthol cigarettes.
• FY '22 appropriations for the Centers for Disease Control and Prevention in the H.R. 4502 FY '22 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies; H.R. 2125, Quit Because of COVID-19 Act; Issues regarding health disparities and tobacco marketing; FDA regulation of tobacco products, including flavored e-cigarettes and menthol cigarettes.
• FY '23 Appropriations for the Department of Health and Human Services, supporting funding for the CDC Office on Smoking and Health; FY '22 Appropriations for the Centers for Disease Control and Prevention in the H.R. 4502 FY '22 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies; H.R. 2125, Quit Because of COVID-19 Act; Issues regarding health disparities and tobacco marketing; FDA regulation of tobacco products, including flavored e-cigarettes and menthol cigarettes.

Related Investigations

Explore More